J. Hiemenz

2.8k total citations · 1 hit paper
23 papers, 2.0k citations indexed

About

J. Hiemenz is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, J. Hiemenz has authored 23 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 9 papers in Infectious Diseases and 8 papers in Oncology. Recurrent topics in J. Hiemenz's work include Antifungal resistance and susceptibility (9 papers), Fungal Infections and Studies (8 papers) and Neutropenia and Cancer Infections (6 papers). J. Hiemenz is often cited by papers focused on Antifungal resistance and susceptibility (9 papers), Fungal Infections and Studies (8 papers) and Neutropenia and Cancer Infections (6 papers). J. Hiemenz collaborates with scholars based in United States, New Zealand and Greece. J. Hiemenz's co-authors include Thomas J. Walsh, E. Anaissie, Emmanuel Roilides, Rhonda Fleming, Andreas H. Groll, Donna A. Wall, Yoichi Satoi, Jeffrey H. Lipton, David H. Vesole and V. Ratanatharathorn and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

J. Hiemenz

22 papers receiving 2.0k citations

Hit Papers

Micafungin versus Fluconazole for Prophylaxis against Inv... 2004 2026 2011 2018 2004 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation
    2004 526 citations V. Ratanatharathorn, Daniel E. Stepan et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Hiemenz United States 13 1.4k 1.3k 398 278 225 23 2.0k
Z. Erjavec Netherlands 16 1.9k 1.3× 1.8k 1.4× 648 1.6× 293 1.1× 200 0.9× 24 2.5k
J Tollemar Sweden 30 1.7k 1.2× 1.7k 1.3× 463 1.2× 177 0.6× 132 0.6× 87 3.1k
Harrys A. Torres United States 35 1.7k 1.2× 2.4k 1.8× 586 1.5× 271 1.0× 158 0.7× 114 3.6k
John W. Hiemenz United States 14 1.4k 0.9× 1.3k 1.0× 322 0.8× 293 1.1× 79 0.4× 28 2.0k
T. J. Walsh United States 18 1.1k 0.8× 1.0k 0.8× 246 0.6× 188 0.7× 208 0.9× 23 1.7k
Jennifer Schranz United States 19 1.9k 1.3× 1.7k 1.3× 236 0.6× 323 1.2× 95 0.4× 45 2.6k
V. A. Morrison United States 14 1.2k 0.8× 1.0k 0.8× 291 0.7× 212 0.8× 119 0.5× 26 1.9k
Jo‐Anne H. van Burik United States 19 930 0.6× 1.1k 0.8× 473 1.2× 176 0.6× 211 0.9× 24 1.9k
Angelika Böhme Germany 23 1.3k 0.9× 1.2k 0.9× 617 1.6× 210 0.8× 138 0.6× 59 1.8k
Fulvio Crippa Italy 8 1.4k 1.0× 1.4k 1.0× 391 1.0× 222 0.8× 132 0.6× 15 1.8k

Countries citing papers authored by J. Hiemenz

Since Specialization
Citations

This map shows the geographic impact of J. Hiemenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Hiemenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Hiemenz more than expected).

Fields of papers citing papers by J. Hiemenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Hiemenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Hiemenz. The network helps show where J. Hiemenz may publish in the future.

Co-authorship network of co-authors of J. Hiemenz

This figure shows the co-authorship network connecting the top 25 collaborators of J. Hiemenz. A scholar is included among the top collaborators of J. Hiemenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Hiemenz. J. Hiemenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Klinker, Kenneth, et al.. (2013). Aztreonam for febrile neutropenia in patients with beta‐lactam allergy. Transplant Infectious Disease. 16(1). 145–152. 7 indexed citations
3.
Hiemenz, J., Issam Raad, J. Maertens, et al.. (2010). Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort. European Journal of Clinical Microbiology & Infectious Diseases. 29(11). 1387–1394. 32 indexed citations
4.
5.
Ratanatharathorn, V., Daniel E. Stepan, Carole B. Miller, et al.. (2004). Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation. Clinical Infectious Diseases. 39(10). 1407–1416. 526 indexed citations breakdown →
6.
Ballester, Oscar, et al.. (2004). Adoptive immunotherapy with donor lymphocyte infusions and interleukin-2 after high-dose therapy and autologous stem cell rescue for multiple myeloma. Bone Marrow Transplantation. 34(5). 419–423. 6 indexed citations
7.
Walsh, Thomas J., Andreas H. Groll, J. Hiemenz, et al.. (2004). Infections due to emerging and uncommon medically important fungal pathogens. Clinical Microbiology and Infection. 10. 48–66. 457 indexed citations
8.
Perfect, John R., G. M. Cox, Carol A. Kauffman, et al.. (2001). The Impact of Culture Isolation ofAspergillusSpecies: A Hospital‐Based Survey of Aspergillosis. Clinical Infectious Diseases. 33(11). 1824–1833. 350 indexed citations
9.
White, Mary H., E. Anaissie, Shimon Kusne, et al.. (1997). Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis.. PubMed. 24(4). 635–42. 133 indexed citations
10.
Tummala, Raj, William E. Janssen, J. Hiemenz, et al.. (1997). High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency. Bone Marrow Transplantation. 20(8). 653–656. 58 indexed citations
11.
Ballester, Oscar, Lynn C. Moscinski, Karen K. Fields, et al.. (1997). Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC‐IE): a novel, intensive induction chemotherapy regimen for patients with high‐risk multiple myeloma. British Journal of Haematology. 96(4). 746–748. 10 indexed citations
12.
Sweeney, J.F., John N. Greene, J. Hiemenz, et al.. (1996). Identification of an amphotericin B resistant strain of Candida albicans using a rapid 3H-glucose incorporation microassay. Journal of Infection. 33(3). 221–226. 3 indexed citations
13.
Brown, Mark A., John N. Greene, Ramón L. Sandin, J. Hiemenz, & John T. Sinnott. (1996). Methylobacterium Bacteremia After Infusion of Contaminated Autologous Bone Marrow. Clinical Infectious Diseases. 23(5). 1191–1192. 12 indexed citations
14.
Fields, Karen K., et al.. (1994). Ifosfamide, carboplatin, and etoposide: a new regimen with a broad spectrum of activity.. Journal of Clinical Oncology. 12(3). 544–552. 45 indexed citations
15.
16.
Fields, Karen K., Gerald J. Elfenbein, Janelle Perkins, et al.. (1993). Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities.. PubMed. 20(5 Suppl 6). 59–66. 30 indexed citations
17.
Browne, Marcia, Dorothy A. Potter, Janet Gress, et al.. (1990). A randomized trial of open lung biopsy versus empiric antimicrobial therapy in cancer patients with diffuse pulmonary infiltrates.. Journal of Clinical Oncology. 8(2). 222–229. 25 indexed citations
18.
Hiemenz, J., et al.. (1990). Invasive fusariosis associated with an injury by a stingray barb. Medical Mycology. 28(3). 209–213. 26 indexed citations
19.
Pizzo, P A, James W. Hathorn, J. Hiemenz, et al.. (1987). A Randomized Trial Comparing Ceftazidime Alone With Combination Antibiotic Therapy in Cancer Patients With Fever and Neutropenia. The Journal of Urology. 137(5). 1067–1068. 145 indexed citations
20.
Pizzo, P A, James R. Commers, Deborah Cotton, et al.. (1984). Approaching the Controversies in Antibacterial Management of Cancer Patients. The Journal of Urology. 132(4). 842–842. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Z. Erjavec Breakdown of academic impact, for papers by J Tollemar Breakdown of academic impact, for papers by Harrys A. Torres Breakdown of academic impact, for papers by John W. Hiemenz Breakdown of academic impact, for papers by T. J. Walsh Breakdown of academic impact, for papers by Jennifer Schranz Breakdown of academic impact, for papers by V. A. Morrison Breakdown of academic impact, for papers by Jo‐Anne H. van Burik Breakdown of academic impact, for papers by Angelika Böhme Breakdown of academic impact, for papers by Fulvio Crippa
Rankless by CCL
2026